• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚夸拉州绍镇基于社区的盘尾丝虫病治疗

The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.

作者信息

Oyibo W A, Fagenro-Beyioku A F

机构信息

Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Nigeria.

出版信息

Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):496-503.

PMID:12693582
Abstract

Community acceptance of and compliance with annual ivermectin treatment in Shao, a sub-urban community in Kwara State, Nigeria, were remarkably high. Of 890 subjects from 204 randomly selected households, 832 (93.5%) had taken ivermectin at least once during the six-year treatment period. An average community acceptance rate (ACAR) of 88.77% (range 85.4 - 91.9%) was recorded during this period; a community compliance rate (CCR) of 74.76% was recorded. Overt refusals, covert refusals and those excluded from treatment were low and insignificant (p > 0.05). The mean compliance age was 37.47 +/- 16.52 years. Of the subjects studied, 40.67% reported adverse reactions to ivermectin during the first round of treatment (Tx1); this number decreased significantly (p < 0.05) to 15.43% during the sixth round of treatment (Tx6). Though considerable adverse reactions were reported in the community, these did not seem to have negatively affected acceptance of and compliance with annual ivermectin treatment; in some cases, the adverse reactions were believed by the villagers to demonstrate the efficacy and effectiveness of the drug. The community showed great awareness of the disease, its treatment with ivermectin and the distribution of the drug. On the basis of the high acceptance and compliance rates, it was concluded that Shao will benefit greatly from the current African Program for Onchocerciasis Control Strategy: Community-Directed Treatment with Ivermectin (CDTI) using Community-Directed Distributors (CDDs).

摘要

在尼日利亚夸拉州的一个城郊社区绍奥,社区对每年一次的伊维菌素治疗的接受度和依从性非常高。在从204个随机选择的家庭中抽取的890名受试者中,832人(93.5%)在六年的治疗期内至少服用过一次伊维菌素。在此期间记录的平均社区接受率(ACAR)为88.77%(范围85.4 - 91.9%);记录的社区依从率(CCR)为74.76%。公开拒绝、暗中拒绝以及被排除在治疗之外的情况很少且不显著(p > 0.05)。平均依从年龄为37.47 +/- 16.52岁。在所研究的受试者中,40.67%在第一轮治疗(Tx1)期间报告了对伊维菌素的不良反应;在第六轮治疗(Tx6)期间,这一数字显著下降(p < 0.05)至15.43%。尽管社区报告了相当多的不良反应,但这些似乎并未对每年一次的伊维菌素治疗的接受度和依从性产生负面影响;在某些情况下,村民们认为这些不良反应证明了该药物的疗效和有效性。该社区对疾病、其伊维菌素治疗以及药物分发表现出了很高的认知度。基于高接受率和依从率,得出的结论是,绍奥将从当前的非洲盘尾丝虫病控制计划战略:使用社区定向分发员(CDD)的社区定向伊维菌素治疗(CDTI)中大大受益。

相似文献

1
The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.尼日利亚夸拉州绍镇基于社区的盘尾丝虫病治疗
Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):496-503.
2
Community response to repeated annual ivermectin treatment of onchocerciasis in Nigeria.尼日利亚社区对盘尾丝虫病年度重复伊维菌素治疗的反应。
Parasitol Res. 2002 Jul;88(7):704-7. doi: 10.1007/s00436-001-0579-y. Epub 2002 Apr 25.
3
Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria.尼日利亚帕蒂吉社区伊维菌素年度治疗盘尾丝虫病依从性评估。
East Afr Med J. 1998 Apr;75(4):237-42.
4
Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?针对伊维菌素社区定向分发商的额外健康与发展活动:对盘尾丝虫病控制而言是威胁还是机遇?
Trop Med Int Health. 2004 Aug;9(8):887-96. doi: 10.1111/j.1365-3156.2004.01285.x.
5
Traditional kinship system enhanced classic community-directed treatment with ivermectin (CDTI) for onchocerciasis control in Uganda.传统亲属关系系统增强了在乌干达使用伊维菌素进行的经典社区定向治疗(CDTI)以控制盘尾丝虫病。
Trans R Soc Trop Med Hyg. 2010 Apr;104(4):265-72. doi: 10.1016/j.trstmh.2009.10.012. Epub 2010 Jan 27.
6
Maintaining compliance to ivermectin in communities in two West African countries.在两个西非国家的社区维持伊维菌素的依从性。
Health Policy Plan. 1996 Sep;11(3):299-307. doi: 10.1093/heapol/11.3.299.
7
Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.基于社区的伊维菌素重复治疗对尼日利亚盘尾丝虫病感染强度的影响。
Rural Remote Health. 2003 Jul-Sep;3(2):211. Epub 2003 Sep 6.
8
Adverse reactions following annual ivermectin treatment of onchocerciasis in Nigeria.尼日利亚年度伊维菌素治疗盘尾丝虫病后的不良反应。
Int J Infect Dis. 2003 Jun;7(2):156-9. doi: 10.1016/s1201-9712(03)90013-0.
9
Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities.孕妇间歇性预防治疗疟疾(IPTp):社区定向伊维菌素分发员参与控制盘尾丝虫病,改善乌干达农村社区的 IPTp 可及性。
Trans R Soc Trop Med Hyg. 2009 Dec;103(12):1221-8. doi: 10.1016/j.trstmh.2009.03.006. Epub 2009 May 20.
10
Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).尼日利亚东南部阿南布拉州的盘尾丝虫病:临床和心理方面以及伊维菌素社区定向治疗(CDTI)的可持续性。
Postgrad Med J. 2010 Oct;86(1020):573-7. doi: 10.1136/pgmj.2010.100248.

引用本文的文献

1
Household coverage of ivermectin distribution in birnin kudu local government area of Jigawa State, Nigeria.尼日利亚吉加瓦州比尔宁-库杜地方政府地区伊维菌素分发的家庭覆盖率。
Ann Afr Med. 2023 Jul-Sep;22(3):252-258. doi: 10.4103/aam.aam_50_20.